Trulieve Cannabis Corp.
TRLV | NYSE
$11.29
+$1.01 (+9.82%)
Nov 2, 2026, 11:26 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 |
|---|---|---|---|---|---|
Net Income | -476.2M | -86.21M | -88.49M | -44.9M | -16.11M |
Depreciation & Amortization | 169.9M | 173.95M | 130.22M | 86.55M | 43.15M |
Stock-Based Compensation | 20.8M | 20.66M | 16.52M | 12.55M | 6.76M |
Other Working Capital | 129.81M | 191.18M | 167.71M | 117.04M | 60.67M |
Other Non-Cash Items | 428.89M | 27.72M | 24.8M | 17.37M | 11.03M |
Deferred Income Tax | -27.65M | -22.12M | -13.9M | -10.02M | -5.27M |
Change in Working Capital | 129.05M | 163.39M | 152.54M | 100.91M | 46.14M |
Operating Cash Flow | 244.8M | 277.4M | 221.69M | 162.48M | 85.7M |
Capital Expenditures | -57.98M | -53.2M | -39.72M | -32.73M | -16.22M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | -393K | n/a | n/a | n/a | 393K |
Other Investing Acitivies | -58.75M | -1.91M | -2.21M | 276K | 2.94M |
Investing Cash Flow | -109.37M | -42.71M | -29.52M | -23.62M | -8.24M |
Debt Repayment | -330.9M | -332.79M | -391.48M | -5.6M | -3.59M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 119.86M | 121.62M | 125.49M | -5M | -2.24M |
Financial Cash Flow | -211.04M | -211.17M | -266M | -10.61M | -5.84M |
Net Cash Flow | -75.61M | 23.52M | -73.82M | 128.25M | 71.63M |
Free Cash Flow | 186.82M | 224.2M | 181.98M | 129.75M | 69.48M |
Adj. Free Cash Flow | 166.02M | 203.54M | 165.45M | 117.2M | 62.72M |
Maintenance CapEx | -57.98M | -53.2M | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | 186.82M | 224.2M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TRLV